Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesTerbinafine (250 mg/day): an effective and safe treatment of cutaneous sporotrichosis
Journal of the European Academy of Dermatology and Venereology, 10/26/09
Francesconi G et al. – The study suggests that 250 mg/day terbinafine is an effective and well–tolerated alternative to drug therapy of cutaneous sporotrichosis in a population in which itraconazole use is not possible.
Related Articles
Zoonotic sporotrichosis of lymphocutaneous type in a man acquired from a domesticated feline source: report of a first case in southern Karnataka, India
International Journal of Dermatology, 10/30/09
Relevance Score: 87%
Oral potassium iodide for the treatment of sporotrichosis
Cochrane Reviews, 10/26/09
Relevance Score: 85%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiofrequency Ablation of Facial Nerve Branches Controlling Glabellar Frowning
Dermatologic Surgery, 12/10/09
Muscle Weakness After Repeated Injection of Botulinum Toxin Type A Evaluated According to Bite Force Measurement of Human Masseter Muscle
Dermatologic Surgery, 12/10/09
Randomized, Placebo-Controlled Study of a New Botulinum Toxin Type A for Treatment of Glabellar Lines: Efficacy and Safety
Dermatologic Surgery, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor